• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Pilocarpine 2% Vitamed
    / Vitamed

    Active Ingredient
    Pilocarpine (HCl) 2%

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Eye Drops

    10 ml

    full basket chart 9378 16174

    Related information


    As needed.
    See package insert (OTC).


    Open-angle glaucoma, angle-closure glaucoma treatment and during and after iridectomy, secondary glaucoma, post-operative miosis induction, and miosis induction following ophthalmoscopy.


    Acute iritis. Risk-benefit should be considered when there is a history or predisposition to retinal detachment, or sensitivity to pilocarpine. Patients wearing soft contact lenses should not use this preparation.

    Special Precautions

    For topical use only. Rare cases of retinal detachment have been reported during treatment with miotic agents, thus care should be exercised with all miotic therapy, especially in young myopic patients. Pregnancy and lactation: Studies have not been done on humans and animals. Ophthalmic pilocarpine may be systemically absorbed. It is not known whether pilocarpine is distributed in to breast milk and problems in humans have not been documented. Patients should be advised to exercise caution in night driving and other hazardous occupations in poor illumination. Regular eye pressure checking during therapy.

    Side Effects

    Lacrimation, burning or discomfort, temporal or periorbital headache, ciliary spasm, conjunctival vascular congestion, superficial keratitis and induced myopia. Reduced visual acuity in poor illumination is frequently experienced by older individuals and in those with lens opacity. Increased sweating, muscle tremors, nausea, vomiting, diarrhea, troubled breathing or wheezing, watering of mouth.

    Drug interactions

    β-blockers, other anticholinergic agonists, anticholinergics.

    Vitamed Pharmaceuticals Ltd.